Related Experiment Video
Updated: Aug 21, 2026

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
Integrin beta4 signaling promotes tumor angiogenesis
Sotiris N Nikolopoulos1, Pamela Blaikie, Toshiaki Yoshioka
1Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Abstract:
Mice carrying a targeted deletion of the signaling portion of the integrin beta4 subunit display drastically reduced angiogenesis in response to bFGF in the Matrigel plug assay and to hypoxia in the retinal neovascularization model. Molecular cytology indicates that alpha6beta4 signaling promotes branching of beta4+ medium- and small-size vessels into beta4- microvessels without exerting a direct effect on endothelial cell proliferation or survival. Signaling studies reveal that alpha6beta4 signaling induces endothelial cell migration and invasion by promoting nuclear translocation of P-ERK and NF-kappaB. Upon subcutaneous implantation of various cancer cells, the mutant mice develop smaller and significantly less vascularized tumors than wild-type controls. These results provide genetic evidence that alpha6beta4 signaling promotes the onset of the invasive phase of pathological angiogenesis and hence identify a novel target for antiangiogenic therapy.
Insights
Integrin alpha6beta4 signaling is crucial for pathological angiogenesis, promoting vessel branching, migration, and invasion. Blocking this pathway in mice significantly reduced tumor vascularization, identifying it as a novel antiangiogenic therapy target.
Area of Science:
- Cellular and Molecular Biology
- Oncology
- Vascular Biology
Background:
- Integrin alpha6beta4 plays a role in cellular adhesion and signaling.
- Angiogenesis, the formation of new blood vessels, is critical for tumor growth and metastasis.
Purpose of the Study:
- To investigate the role of integrin alpha6beta4 signaling in angiogenesis and tumor development.
- To determine if alpha6beta4 signaling is a viable target for antiangiogenic therapies.
Main Methods:
- Utilized a mouse model with a targeted deletion of the integrin beta4 subunit's signaling portion.
- Assessed angiogenesis using the Matrigel plug assay and a retinal neovascularization model.
- Analyzed tumor growth and vascularization in mutant and wild-type mice bearing cancer cell xenografts.
Main Results:
- Mice with deleted integrin beta4 signaling showed significantly reduced angiogenesis in response to bFGF and hypoxia.
- Alpha6beta4 signaling promoted endothelial cell migration and invasion, not proliferation or survival.
- Tumors in mutant mice were smaller and less vascularized compared to controls.
- Signaling pathways involving P-ERK and NF-kappaB were implicated in alpha6beta4-mediated endothelial cell responses.
Conclusions:
- Integrin alpha6beta4 signaling is essential for the invasive phase of pathological angiogenesis.
- Targeting alpha6beta4 signaling represents a novel strategy for antiangiogenic therapy.
More Related Videos
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
The Tumor Microenvironment
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...

